- Home
- AAL vs AXSM Comparison
AAL vs AXSM Comparison
Compare AAL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAL | AXSM |
|---|---|---|
| Founded | 1930 | 2012 |
| Country | United States | United States |
| Employees | 133700 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.0B |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AAL | AXSM |
|---|---|---|
| Price | $11.20 | $162.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 17 |
| Target Price | $16.58 | ★ $209.18 |
| AVG Volume (30 Days) | ★ 55.2M | 510.2K |
| Earning Date | 04-27-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $54,633,000,000.00 | N/A |
| Revenue This Year | $10.06 | $61.00 |
| Revenue Next Year | $5.67 | $54.38 |
| P/E Ratio | $69.29 | ★ N/A |
| Revenue Growth | ★ 0.78 | N/A |
| 52 Week Low | $8.50 | $86.99 |
| 52 Week High | $16.50 | $191.50 |
Technical Indicators
Market Signals| Indicator | AAL | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 29.45 | 34.56 |
| Support Level | $10.76 | $148.14 |
| Resistance Level | $11.96 | $191.13 |
| Average True Range (ATR) | 0.58 | 5.57 |
| MACD | -0.20 | -2.00 |
| Stochastic Oscillator | 3.45 | 14.86 |
Price Performance
Historical ComparisonAbout AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.